Adriatic
Argentina
Asia-Pacific
Australia and New Zealand
Bangladesh
Belgique (Belgium)
België (Belgium)
Brasil (Brazil)
Bulgaria
Canada
Canada
Česká republika (Czech Republic)
Chile
中国 (China)
Colombia
Costa Rica
Србија (Serbia)
Danmark (Denmark)
Deutschland (Germany)
Ecuador
España (Spain)
Europe
France
Ελλάδα (Greece)
香港特区 (Hong Kong SAR)
Indian Subcontinent
Ireland
Israel ישראל
Italia (Italy)
日本 (Japan)
Latinoamérica
Magyarország (Hungary)
México (Mexico)
Middle East and North Africa
Nederland (Netherlands)
Norge (Norway)
Österreich (Austria)
Panama
Portugal
Paraguay
Perú (Peru)
Polska (Poland)
Российская Федерация (Russia)
Puerto Rico
Romania
Schweiz (Switzerland)
Slovenská republika (Slovak Republic)
Southeast Asia
South Africa and Sub-Sahara
대한민국 (South Korea)
Suisse (Switzerland)
Suomi (Finland)
Sverige (Sweden)
台湾地区 (Taiwan)
Türkiye (Turkey)
United Kingdom
United States
Uruguay
Україна (Ukraine)
Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 9, 2014Latest Results from Two Clinical Studies Show Strong Mid-Term Performance of Leading Medical Device for Endovascular Repair of Abdominal Aortic Aneurysms
MINNEAPOLIS -- Dec. 9, 2014 -- For endovascular repair of abdominal aortic aneurysms, the Endurant AAA stent graft system from Medtronic, Inc. (NYSE: MDT) continues to deliver durable, consistent...
-
Dec 8, 2014Grants Help Mark Five Years Since Diabetes Therapy Management and Education Center Opened its Doors
SAN ANTONIO, TX - December 8, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that five San Antonio community organizations will receive a combined $250,000 in Health Access Grants in...
-
Dec 8, 2014Medtronic Philanthropy Program Honors Ten Individuals Around the World with $20,000 Charitable Grants to Their Causes
MINNEAPOLIS - December 8, 2014 - Medtronic (NYSE: MDT) today announced the names of 10 people from around the world who will be honored as part of the Bakken Invitation, a global program launched...
-
Dec 5, 2014
MINNEAPOLIS - Dec 5, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 25th Annual Oppenheimer Healthcare Conference on...
-
Dec 5, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 5, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 4, 2014"Delivering Societal Value through Responsible Growth" Reviews Company's Economic, Social and Environmental Performance for Fiscal Year 2014
MINNEAPOLIS - Dec. 3, 2014 - Medtronic, Inc. (NYSE:MDT) has released "Delivering Societal Value through Responsible Growth," the company's 2014 Integrated Performance Report. The company's first...
-
Dec 4, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Dec 4, 2014
MINNEAPOLIS AND DUBLIN, Ireland - Dec. 4, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic's proposed...
-
Dec 4, 2014
MINNEAPOLIS AND DUBLIN, Ireland - Dec. 4, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic's proposed...
-
Dec 4, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 4, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 4, 2014
MINNEAPOLIS - December 4, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the Company's common stock. The dividend is payable on...
-
Dec 1, 2014
MINNEAPOLIS - December 1, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the pricing of $17 billion aggregate principal amount of senior notes in seven tranches, as follows: Description Amount...
-
Nov 30, 2014First and Only DES with Novel CoreWire Technology Allows for Thinner, Stronger Struts, Enhanced Deliverability and Radiopacity without Compromising Structural Strength
MINNEAPOLIS - Nov. 3, 2014 - Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations, Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Europé
-
Nov 28, 2014
MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s...
-
Nov 26, 2014
MINNEAPOLIS AND DUBLIN, Ireland - Nov. 26, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of...
-
Nov 24, 2014Fortrex™ PTA Balloon Facilitates Arteriovenous Access in Patients Receiving Hemodialysis for Chronic Kidney Disease
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 24, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for its Fortrex™ over-the-wire (OTW) percutaneous...
-
Nov 21, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 21, 2014-- Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the definitive joint proxy statement of Covidien plc and...
-
Nov 20, 2014New device is the only commercially available bedside monitor designed for home care and sleep study settings
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 20, 2014-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N. The system currently is...
-
Nov 19, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 19, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Nov 18, 2014Revenue of $4.4 Billion Grew 5% on Constant Currency Basis; 4% as Reported
MINNEAPOLIS - Nov. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2015, which ended October 24, 2014. The company reported worldwide...
-
Nov 17, 2014
MINNEAPOLIS AND DUBLIN - Nov. 17, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) announced that following a hearing today before the Irish High Court the companies have scheduled...
-
Nov 16, 2014Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital ReadmissionsData Demonstrate Clinical and Economic Value of Underutilized Treatment for Heart Failure Patients at American Heart Association's Scientific Sessions 2014
MINNEAPOLIS and CHICAGO - Nov. 16, 2014 - Medtronic, Inc. (NYSE: MDT) today announced new data supporting the clinical and economic value of its cardiac resynchronization therapy (CRT) devices for...
-
Nov 13, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 13, 2014Data Demonstrate Strong Closure Rates in Patients with Chronic Venous Insufficiency, Varicose Veins
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 13, 2014-- Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the...
-
Nov 13, 2014
Covidien plc: IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT...
-
Nov 13, 2014Data Presented at Kidney Week 2014 Find Irregular Heartbeats Occur Frequently Around Hemodialysis Sessions
MINNEAPOLIS and PHILADELPHIA - Nov. 13, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed the results of a new study which found that atrial fibrillation (AF) and bradycardia-two common heart...
-
Nov 12, 2014New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms
MINNEAPOLIS -- Nov. 12, 2014 -- The global leader in medical technology for endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT) today announced the launch in Europe and the United...
-
Nov 10, 2014Evera MRI(TM) ICD System Combines Proven Treatment Performance, Increased Longevity and Improved Comfort with Full-Body MRI Access
MINNEAPOLIS - Nov. 10, 2014 - Medtronic today announced Japanese regulatory approval and launch of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System for magnetic...
-
Nov 10, 2014
MINNEAPOLIS - Nov 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2015 on Tuesday, November 18, 2014. A news...
-
Nov 7, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 5, 2014
MINNEAPOLIS, Nov. 5, 2014 - Today marks the launch of a new Harvard Business Review (HBR) Insight Center, exclusively sponsored by Medtronic, which provides a forum for thought-leading commentary,...
-
Nov 5, 2014Fourth-quarter net sales up 7%; Medical Devices sales up 8%
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced financial results for the fourth quarter of fiscal 2014. Fourth-quarter net sales of $2.73 billion...
-
Nov 5, 2014EverFlex™ Self-Expanding Stent System Safe and Effective for the Treatment of Iliac Stenosis
LAS VEGAS--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex™ stent...
-
Nov 4, 2014Employee Engagement, Philanthropy Among Top Reasons for Selection
BRAMPTON, ONTARIO - November 4, 2014 - Medtronic of Canada Ltd., a trusted Canadian leader in innovative medical technologies and health system solutions, is pleased to have been recognized as one...
-
Nov 4, 2014Consistent Outcomes Despite Common and Challenging Comorbidity Reinforce Overall Findings of IN.PACT SFA Trial
LAS VEGAS -- Nov. 4, 2014 -- For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic, Inc. (NYSE: MDT) provided a...
-
Nov 4, 2014The HawkOne™ System strengthens Covidien’s directional atherectomy platform with a versatile solution for the treatment of peripheral arterial disease
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the HawkOne™ directional atherectomy system. The...
-
Nov 4, 2014Results suggest long-term benefits for peripheral artery disease patients treated with directional atherectomy followed by a drug-coated balloon
LAS VEGAS--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical...
-
Nov 2, 2014Expands Spectranetics' portfolio of solutions to treat complex vascular conditions in projected $700 million drug coated balloon segment
COLORADO SPRINGS, Colo., and DUBLIN, Ireland, Nov. 2, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) and Covidien plc (NYSE:COV) today announced a definitive agreement under...
-
Oct 30, 2014- Record 675 HeartWare® Ventricular Assist Systems sold worldwide in Q3
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Oct 28, 2014ReliaTack™ device delivers superior access, stronger fixation and lower cost of care for minimally invasive hernia repair
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 28, 2014-- Covidien plc (NYSE:COV) today announced the launch of ReliaTack™ articulating reloadable fixation device, the first and only of its kind for...
-
Oct 28, 2014
MINNEAPOLIS - October 28, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has initiated the PERIGON (PERIcardial SurGical AOrtic Valve ReplacemeNt) Pivotal Trial, a global, prospective...
-
Oct 27, 2014Covidien Launches Next-Generation SuperDimension™ Lung Navigation Software to Simplify Planning, Enhance Visualization During a Procedure
DUBLIN--(BUSINESS WIRE)--Oct. 27, 2014-- Further underscoring its ongoing commitment to lung health, Covidien (NYSE:COV) today unveiled a next-generation version of its superDimension™...
-
Oct 23, 2014Lung cancer is the number one cancer killer of women
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 23, 2014-- Covidien (NYSE: COV) is joining forces with the American Lung Association’s LUNG FORCE movement to raise awareness of the threat that lung...
-
Oct 21, 2014System Offers New Approach to Single-Level ACDF Procedures
MEMPHIS, TENN. - October 21, 2014 - Medtronic, Inc. (NYSE: MDT) announced the U.S. launch of the DIVERGENCE(TM) Anterior Cervical Fusion System for the treatment of single-level cervical disc...
-
Oct 21, 2014Covidien-World Stroke Organization Survey Shows Low Knowledge of Stroke Prevention, Treatment Options
Dublin, Ireland and Geneva – Oct. 22, 2014 – Despite its being the second leading cause of death worldwide, many people still do not recognize the threat stroke poses and the warning signs...
-
Oct 20, 2014
MEMPHIS, TENN., - October 20, 2014 - Medtronic, Inc. (NYSE: MDT) introduced its Pure Titanium Coating (PTC) platform of interbody fusion devices for the spine today at the 2014 Congress of...
-
Oct 17, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 17, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against...
-
Oct 15, 2014
HeartWare International, Inc. (NASDAQ: HTWR) has scheduled a conference call to discuss its financial results for the three months ended September 30, 2014, at 8:00 a.m. U.S. Eastern Daylight Time...
-
Oct 14, 2014In-Clinic Study Marks Critical Step Toward an Artificial Pancreas and Key Milestone Toward U.S. Commercialization
MINNEAPOLIS - October 14, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough...
-
Oct 13, 2014Late-Breaking ADVANCE Direct Aortic Study Presented at EACTS Reaffirms CoreValve System's Positive Performance with Low Mortality and Stroke
MINNEAPOLIS and MILAN - Oct. 13, 2014 -Medtronic, Inc. (NYSE: MDT) today announced positive data from nine European centers in a study of the direct aortic approach (through the upper chest) with...